The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGENUS INC | Common | 00847G705 | 10,847 | 2,459,554 | SH | SOLE | 2,459,554 | 0 | 0 | ||
| ALIMERA SCIENCES INC | Common | 016259103 | 8,426 | 6,241,581 | SH | SOLE | 6,241,581 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 97,072 | 6,437,122 | SH | SOLE | 6,437,122 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 2,550 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 3,150 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 2,700 | 1,000,000 | SH | Call | SOLE | 1,000,000 | 0 | 0 | |
| ARGENX SE | Sponsored ADR | 04016X101 | 9,713 | 429,600 | SH | SOLE | 429,600 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | Common | 04269X105 | 65,842 | 5,353,029 | SH | SOLE | 5,353,029 | 0 | 0 | ||
| ARRAY BIOPHARMA INC | Common | 04269X105 | 1,500 | 500,000 | SH | Call | SOLE | 500,000 | 0 | 0 | |
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 59,309 | 1,636,124 | SH | SOLE | 1,636,124 | 0 | 0 | ||
| ASSEMBLY BIOSCIENCES INC | Common | 045396108 | 31,678 | 907,162 | SH | SOLE | 907,162 | 0 | 0 | ||
| AVEO PHARMACEUTICALS INC | Common | 053588109 | 17,543 | 4,806,249 | SH | SOLE | 4,806,249 | 0 | 0 | ||
| AVEXIS INC | Common | 05366U100 | 42,242 | 436,702 | SH | SOLE | 436,702 | 0 | 0 | ||
| BIOCRYST PHARMACEUTICALS INC | Common | 09058V103 | 9,319 | 1,778,525 | SH | SOLE | 1,778,525 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 55,653 | 597,972 | SH | SOLE | 597,972 | 0 | 0 | ||
| CASCADIAN THERAPEUTICS INC | Common | 14740B606 | 7,449 | 1,821,248 | SH | SOLE | 1,821,248 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | Common | 14888U101 | 11,682 | 4,635,745 | SH | SOLE | 4,635,745 | 0 | 0 | ||
| CELLECTIS S A | Sponsored ADS | 15117K103 | 2,227 | 78,289 | SH | SOLE | 78,289 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC | Common | 189464100 | 64,742 | 785,700 | SH | SOLE | 785,700 | 0 | 0 | ||
| DBV TECHNOLOGIES S A | Sponsored ADR | 23306J101 | 8,216 | 193,600 | SH | SOLE | 193,600 | 0 | 0 | ||
| DERMIRA INC | Common | 24983L104 | 41,040 | 1,520,000 | SH | SOLE | 1,520,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 731 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
| GLOBAL BLOOD THERAPEUTICS INC | Common | 37890U108 | 34,910 | 1,124,300 | SH | SOLE | 1,124,300 | 0 | 0 | ||
| HORIZON PHARMA PLC | Common | G4617B105 | 44,584 | 3,516,100 | SH | SOLE | 3,516,100 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 206,058 | 14,739,461 | SH | SOLE | 14,739,461 | 0 | 0 | ||
| IMMUNOMEDICS INC | Common | 452907108 | 6,300 | 875,000 | SH | Call | SOLE | 875,000 | 0 | 0 | |
| INTEC PHARMA LTD | Common | M53644106 | 19,652 | 2,195,705 | SH | SOLE | 2,195,705 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 32,560 | 4,201,343 | SH | SOLE | 4,201,343 | 0 | 0 | ||
| KITE PHARMA INC | Common | 49803L109 | 89,363 | 496,983 | SH | SOLE | 496,983 | 0 | 0 | ||
| MEDICINES CO | Common | 584688105 | 63,723 | 1,720,393 | SH | SOLE | 1,720,393 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 43,414 | 3,710,601 | SH | SOLE | 3,710,601 | 0 | 0 | ||
| MYOKARDIA INC | Common | 62857M105 | 17,063 | 398,207 | SH | SOLE | 398,207 | 0 | 0 | ||
| ONCOBIOLOGICS INC | Common | 68235M105 | 936 | 683,531 | SH | SOLE | 683,531 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT A | Warrant | 68235M113 | 28 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| ONCOBIOLOGICS INC - WARRANT B | Warrant | 68235M121 | 12 | 233,333 | SH | SOLE | 233,333 | 0 | 0 | ||
| OVASCIENCE INC | Common | 69014Q101 | 1,593 | 1,121,952 | SH | SOLE | 1,121,952 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | Common | 695127100 | 49,245 | 1,311,460 | SH | SOLE | 1,311,460 | 0 | 0 | ||
| PERNIX THERAPEUTICS HOLDINGS INC | Convertible Debt | 71426VAK4 | 2,526 | 6,000,000 | PRN | SOLE | 6,000,000 | 0 | 0 | ||
| SPDR S&P 500 ETF | Put | 78462F103 | 469 | 250,000 | SH | Put | SOLE | 250,000 | 0 | 0 | |
| TELIGENT INC | Common | 87960W104 | 30,720 | 4,578,230 | SH | SOLE | 4,578,230 | 0 | 0 | ||
| TESARO INC | Common | 881569107 | 25,186 | 195,092 | SH | SOLE | 195,092 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | Common | 921659108 | 17,690 | 988,270 | SH | SOLE | 988,270 | 0 | 0 | ||
| VERACYTE INC | Common | 92337F107 | 8,217 | 936,909 | SH | SOLE | 936,909 | 0 | 0 | ||
| VIVEVE MEDICAL INC | Common | 92852W204 | 5,414 | 1,033,276 | SH | SOLE | 1,033,276 | 0 | 0 | ||
| ZOGENIX INC | Common | 98978L204 | 35,974 | 1,026,368 | SH | SOLE | 1,026,368 | 0 | 0 | ||